Advanced search
Publication Cover
International Journal of Nanomedicine Volume 14, 2019 - Issue
Submit an article Journal homepage
114
Views
24
CrossRef citations to date
0
Altmetric
Original Research

Co-delivery doxorubicin and silybin for anti-hepatoma via enhanced oral hepatic-targeted efficiency

Ying LiDrug Delivery Research Center, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, People’s Republic of China, [email protected]
,
Dandan YangDrug Delivery Research Center, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, People’s Republic of China, [email protected]
,
Yian WangDrug Delivery Research Center, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, People’s Republic of China, [email protected]
,
Zhan LiDrug Delivery Research Center, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, People’s Republic of China, [email protected]
&
Chunyan ZhuDrug Delivery Research Center, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, People’s Republic of China, [email protected]Correspondence[email protected]
Pages 301-315 | Published online: 28 Dec 2018

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Meghanath B. Shete, Ashwini S. Deshpande & Pravin Shende. (2022) Silybin-based herbal nanocarriers: an advancement in anticancer therapy. Materials Technology 37:13, pages 2832-2852.
Read now

Articles from other publishers (23)

Yuehong Ren, Wei Wu & Xingwang Zhang. (2023) The feasibility of oral targeted drug delivery: Gut immune to particulates?. Acta Pharmaceutica Sinica B 13:6, pages 2544-2558.
Crossref
Qian Zhang, Minghui Tong, Huarong Xu, Yidi Yin, Peng Gao, Kaishun Bi, Yiwen Zhang & Qing Li. (2023) Accurate determination for lipidomics based on LC-tandem-MS parameters modeling, prediction, and database: Monitoring the progression of hepatocellular carcinoma. Journal of Pharmaceutical and Biomedical Analysis 223, pages 115126.
Crossref
Mahsa Ghodousi, Hedyieh Karbasforooshan, Leila Arabi & Sepideh Elyasi. (2022) Silymarin as a preventive or therapeutic measure for chemotherapy and radiotherapy-induced adverse reactions: a comprehensive review of preclinical and clinical data. European Journal of Clinical Pharmacology 79:1, pages 15-38.
Crossref
Leqi Wang, Qi Liu, Xinping Hu, Chuhang Zhou, Yining Ma, Xiaoxiao Wang, Yingwei Tang, Kanghao Chen, Xinyu Wang & Yan Liu. (2022) Enhanced Oral Absorption and Liver Distribution of Polymeric Nanoparticles through Traveling the Enterohepatic Circulation Pathways of Bile Acid. ACS Applied Materials & Interfaces 14:37, pages 41712-41725.
Crossref
Wenbiao Li, Xinni Qu, Xiangping Kang, Haiyin Zhang, Xueli Zhang, Haiyan Hu, Lingai Yao, Lina Zhang, Jing Zheng, Yuejuan Zheng, Jianghong Zhang & Yanwu Xu. (2022) Silibinin eliminates mitochondrial ROS and restores autophagy through IL6ST/JAK2/STAT3 signaling pathway to protect cardiomyocytes from doxorubicin-induced injury. European Journal of Pharmacology 929, pages 175153.
Crossref
Morgane Renault–Mahieux, Nathalie Mignet, Johanne Seguin, Khair Alhareth, Muriel Paul & Karine Andrieux. (2022) Co–encapsulation of flavonoids with anti–cancer drugs: A challenge ahead. International Journal of Pharmaceutics 623, pages 121942.
Crossref
Bian-Wen Qiao, Xin-Tong Liu, Chen-Xin Wang, Shuang Song, Chun-Qing Ai & Ying-Huan Fu. (2022) Preparation, Characterization, and Antioxidant Properties of Phycocyanin Complexes Based on Sodium Alginate and Lysozyme. Frontiers in Nutrition 9.
Crossref
Khaled Mahmoud, Shady Swidan, Mohamed El-Nabarawi & Mahmoud Teaima. (2022) Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances. Journal of Nanobiotechnology 20:1.
Crossref
Aygul Can, Arwen I.I. Tyler & Alan R. Mackie. (2021) Potential use of bile salts in lipid self-assembled systems for the delivery of phytochemicals. Current Opinion in Colloid & Interface Science 56, pages 101502.
Crossref
Shuli Man, Chen Luo, Mengyao Yan, Ganggang Zhao, Long Ma & Wenyuan Gao. (2021) Treatment for liver cancer: From sorafenib to natural products. European Journal of Medicinal Chemistry 224, pages 113690.
Crossref
Daisong Li, Yanyan Yang, Shizhong Wang, Xiangqin He, Meixin Liu, Baochen Bai, Chao Tian, Ruicong Sun, Tao Yu & Xianming Chu. (2021) Role of acetylation in doxorubicin-induced cardiotoxicity. Redox Biology 46, pages 102089.
Crossref
Julia A. Hotinger, Seth T. Morris & Aaron E. May. (2021) The Case against Antibiotics and for Anti-Virulence Therapeutics. Microorganisms 9:10, pages 2049.
Crossref
Eric Mühlberg, Mira Burtscher, Florian Umstätter, Gert Fricker, Walter Mier & Philipp Uhl. (2021) Trends in liposomal nanocarrier strategies for the oral delivery of biologics. Nanomedicine 16:20, pages 1813-1832.
Crossref
Cijo George Vazhappilly, Madumani Amararathna, Asha Caroline Cyril, Rebecca Linger, Rachel Matar, Maxime Merheb, Wafaa S Ramadan, Rajan Radhakrishnan & H.P. Vasantha Rupasinghe. (2021) Current methodologies to refine bioavailability, delivery, and therapeutic efficacy of plant flavonoids in cancer treatment. The Journal of Nutritional Biochemistry 94, pages 108623.
Crossref
Subhasish Sahoo, Pooja Ghosh, Supratim Banerjee & Priyadarsi De. (2021) Recent Advances in Biomedical Applications of Cholic Acid-Based Macromolecules. ACS Applied Polymer Materials 3:4, pages 1687-1706.
Crossref
Mengmeng Zheng, Siqi Gao, Yamin Lin, Yating Lin, Zufang Huang, Shusen Xie, Yun Yu & Juqiang Lin. (2020) Surface‐enhanced Raman scattering of secretory proteins for the cytotoxicity analysis of low‐dose doxorubicin. Journal of Raman Spectroscopy 51:11, pages 2217-2226.
Crossref
Diana S. Antal, Florina Ardelean, Stefana Avram, Ioana Z. Pavel, Corina Danciu, Codruta Soica & Cristina Dehelean. (2020) Flavonolignans: One Step Further in the Broad-Spectrum Approach of Cancer. Anti-Cancer Agents in Medicinal Chemistry 20:15, pages 1817-1830.
Crossref
Xiaocheng Li, Wenbin Diao, Hantao Xue, Fei Wu, Weiyu Wang, Bin Jiang, Jingkun Bai, Bo Lian, Weiguo Feng, Tongyi Sun, Wenjing Yu, Jingliang Wu, Meihua Qu, Yubing Wang & Zhiqin Gao. (2020) Improved efficacy of doxorubicin delivery by a novel dual-ligand-modified liposome in hepatocellular carcinoma. Cancer Letters 489, pages 163-173.
Crossref
Dominique Delmas, Jianbo Xiao, Anne Vejux & Virginie Aires. (2020) Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and Chemosensitivity. Molecules 25:9, pages 2009.
Crossref
Adil Farooq Wali, Summya Rashid, Shahzada Mudasir Rashid, Mushtaq Ahmad Ansari, Mohammad Rashid Khan, Nazrul Haq, Dhafer Yahya Alhareth, Ajaz Ahmad & Muneeb U. Rehman. (2020) Naringenin Regulates Doxorubicin-Induced Liver Dysfunction: Impact on Oxidative Stress and Inflammation. Plants 9:4, pages 550.
Crossref
Yu Zhang, Zheng Cui, Hao Mei, Jingya Xu, Tao Zhou, Fang Cheng & Kaiping Wang. (2019) Angelica sinensis polysaccharide nanoparticles as a targeted drug delivery system for enhanced therapy of liver cancer. Carbohydrate Polymers 219, pages 143-154.
Crossref
Reza Baradaran Eftekhari, Niloufar Maghsoudnia, Shabnam Samimi, Ali Zamzami & Farid Abedin Dorkoosh. (2019) Co-Delivery Nanosystems for Cancer Treatment: A Review. Pharmaceutical Nanotechnology 7:2, pages 90-112.
Crossref
Shatadal Ghosh, Sumit Ghosh & Parames C. Sil. (2019) Role of nanostructures in improvising oral medicine. Toxicology Reports 6, pages 358-368.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.